January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the 'Company'), a global ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced today that it has entered into a strategic collaboration with Invetx, Inc.

Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed SOUTH SAN FRANCISCO, ...

Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current ...

Cambridge, Massachusetts Thursday, February 6, 2025, 13:00 Hrs [IST] ...

Researchers used an AI-driven approach to identify adalimumab as a potential life-saving treatment for idiopathic ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.